Startup entity
product-launch is the sole category represented across all 1 tracked stories. AI Antidote Development Model is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 7, the average consequence score sits above the same-window beat average of 6.6.
Last mentioned: Mar 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
product-launch is the sole category represented across all 1 tracked stories. AI Antidote Development Model is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 7, the average consequence score sits above the same-window beat average of 6.6. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. We currently track 1 Startup story that mention U.S. Countermeasure Programs, all published on March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 48 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering U.S. Countermeasure Programs. Shared-story counts are live from our verified record — not editorial picks.
Cycle Completion
Target completion for the first 3-year development cycle under the new model.
First Milestone
Anticipated first-round validation of AI-modeled antidote candidates.
Bidding Window
Expected commencement of bidding for initial U.S. countermeasure contracts.
Consortium Launch
Lunai Bioworks officially establishes the National Chemical Defense Consortium.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to secure up to $1.2 billion in U.S. government countermeasure contracts. The initiative centers on a proprietary three-year AI-driven model designed to accelerate the development of chemical antidotes.
U.S. Countermeasure Programs is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
